Catalyst Wire Dossier Catalyst Wire Dossier

Omicron BA.4/5-Delta Strain Recombinant Novel Coronavirus Protein Vaccine (CHO Cells)

· Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Omicron BA.4/5-Delta Strain Recombinant Novel Coronavirus Protein Vaccine (CHO Cells), covering 2024-05-13 to 2024-05-13. Get the full timeline:

Most recent: Clinical Trial Update: Omicron BA.4/5-Delta Strain Recombinant Novel Coronavirus Protein Vaccine (CHO Cells) [NA]

See pricing